AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Troubled Journey of 23andMe
This chapter explores the dramatic decline of 23andMe, detailing its stock plunge, the risk of delisting, and the resignation of its board. It contrasts the company's promising inception aimed at democratizing genetic insights with the challenges it faced, including regulatory issues and the complexities of consumer DNA testing.